{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-045860","form_type":"8-K","ticker":"TELO","cik":"0001971532","company_name":"Telomir Pharmaceuticals, Inc.","filed_at":"2026-10-06T12:00:29+00:00","discovered_at":"2026-10-06T12:05:00.301265+00:00","generated_at":"2026-10-12T16:34:47.840100+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Telomir raises $5.6M in common-stock PIPE at $1.16/share; DeJoria adds $1.0M","bullets":["PIPE of 4,843,300 common shares at $1.16/share, a 5% discount to the 10-day VWAP ending two days before the Oct. 5, 2026 closing; gross proceeds ~$5.6M.","Existing significant shareholder John Paul DeJoria (reported ~3.55M shares, ~5.0% of outstanding) invested an additional $1.0M; other existing and new investors also participated.","Alexander Capital placed the deal: 9.0% cash fee (~$455,000), expense reimbursement capped at $40,000, plus 387,464 five-year warrants at $1.16/share.","Net proceeds fund Telomir-Zn's Phase 1/2 trial in advanced or metastatic triple-negative breast cancer under an FDA-cleared IND, plus working capital and general corporate purposes.","No investor warrants, convertibles or price-reset features; Telomir must file a resale registration statement within 30 days of closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-045860","json":"https://secwatch.observer/filing/0001493152-26-045860.json","markdown":"https://secwatch.observer/filing/0001493152-26-045860.md","text":"https://secwatch.observer/filing/0001493152-26-045860.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226045860/0001493152-26-045860-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226045860/form8-k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T16:34:47.840100+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}